SYA dark blue font on white background (1).jpg
Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation
14 mars 2023 08h05 HE | Syapse
SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
Syneos Health_rgb_r.jpg
Syneos Health Adds HUB Patient Suite to Deployment Solutions Business
27 oct. 2022 07h30 HE | Syneos Health, Inc.
MORRISVILLE, N.C., Oct. 27, 2022 (GLOBE NEWSWIRE) -- Syneos Health® (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization, today announced it is introducing a dedicated...
Setareh Williams
Setareh Williams Joins Cobbs Creek Healthcare as Managing Partner/Head of Real-World Evidence and Scientific Communications
04 mai 2022 09h00 HE | Cobbs Creek Healthcare
Newtown Square PA, May 04, 2022 (GLOBE NEWSWIRE) -- Cobbs Creek Healthcare, a data science and advanced analytics firm transforming healthcare decision-making through innovative insights and a...
The real world evidence (RWE) market is projected to be worth USD 4.5 billion by 2030, growing at a CAGR of 15%, claims Roots Analysis
03 mars 2021 08h45 HE | Roots Analysis
London, March 03, 2021 (GLOBE NEWSWIRE) -- Roots Analysis has announced the addition of “Pharmaceutical and Life Sciences Real World Evidence Market, (2nd Edition), 2021-2030” report to its list of...
Syneos Health and ConcertAI Announce Strategic Collaboration to Accelerate the Use of Real World Evidence and AI to Advance Oncology Research
03 déc. 2020 08h49 HE | Syneos Health, Inc.
BOSTON and MORRISVILLE, N.C., Dec. 03, 2020 (GLOBE NEWSWIRE) -- Syneos Health (Nasdaq:SYNH), the only fully integrated biopharmaceutical solutions organization and ConcertAI, the leader in oncology...
logo big square.png
Syapse Announces Research Collaboration with the FDA Focused on the Regulatory Use of Real-World Evidence
14 août 2019 06h00 HE | Syapse
SAN FRANCISCO, Aug. 14, 2019 (GLOBE NEWSWIRE) -- Syapse and the U.S. Food and Drug Administration (FDA) Oncology Center of Excellence (OCE) have signed a multi-year Research Collaboration Agreement...